A detailed history of Machina Capital S.A.S. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Machina Capital S.A.S. holds 2,117 shares of VRTX stock, worth $1.01 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
2,117
Previous 1,994 6.17%
Holding current value
$1.01 Million
Previous $833,000 19.09%
% of portfolio
0.46%
Previous 0.45%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$392.81 - $485.53 $48,315 - $59,720
123 Added 6.17%
2,117 $992,000
Q1 2024

May 13, 2024

BUY
$407.69 - $446.08 $812,933 - $889,483
1,994 New
1,994 $833,000
Q3 2023

Nov 02, 2023

BUY
$338.18 - $362.46 $794,046 - $851,056
2,348 New
2,348 $816,000
Q1 2023

Apr 24, 2023

SELL
$283.23 - $323.1 $56,646 - $64,620
-200 Reduced 18.18%
900 $283,000
Q4 2022

Feb 08, 2023

BUY
$285.76 - $321.48 $314,336 - $353,628
1,100 New
1,100 $317,000
Q1 2020

May 05, 2020

SELL
$199.77 - $247.81 $695,399 - $862,626
-3,481 Closed
0 $0
Q4 2019

Feb 07, 2020

SELL
$166.71 - $223.91 $208,554 - $280,111
-1,251 Reduced 26.44%
3,481 $762,000
Q3 2019

Nov 12, 2019

SELL
$166.23 - $187.09 $123,508 - $139,007
-743 Reduced 13.57%
4,732 $802,000
Q2 2019

Jul 19, 2019

SELL
$164.61 - $190.37 $1.51 Million - $1.75 Million
-9,172 Reduced 62.62%
5,475 $1 Million
Q1 2019

May 14, 2019

BUY
$163.73 - $194.7 $2.26 Million - $2.68 Million
13,780 Added 1589.39%
14,647 $2.69 Million
Q4 2018

Mar 25, 2019

BUY
$151.91 - $192.21 $131,705 - $166,646
867 New
867 $144,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $123B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Machina Capital S.A.S. Portfolio

Follow Machina Capital S.A.S. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Machina Capital S.A.S., based on Form 13F filings with the SEC.

News

Stay updated on Machina Capital S.A.S. with notifications on news.